PortfoliosLab logo

Royalty Pharma plc

RPRX
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
GB00BMVP7Y09
CUSIP
00BMVP7Y0

RPRXPrice Chart


Chart placeholderClick Calculate to get results

RPRXPerformance

The chart shows the growth of $10,000 invested in Royalty Pharma plc on Jun 17, 2020 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $8,594 for a total return of roughly -14.06%. All prices are adjusted for splits and dividends.


RPRX (Royalty Pharma plc)
Benchmark (S&P 500)

RPRXReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M2.38%
6M-12.47%
YTD-24.16%
1Y-2.32%
5Y-10.56%
10Y-10.56%

RPRXMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

RPRXSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Royalty Pharma plc Sharpe ratio is -0.09. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


RPRX (Royalty Pharma plc)
Benchmark (S&P 500)

RPRXDividends

Royalty Pharma plc granted a 1.76% dividend yield in the last twelve months, as of Oct 23, 2021. The annual payout for that period amounted to $0.66 per share.


PeriodTTM2020
Dividend$0.66$0.30

Dividend yield

1.76%0.60%

RPRXDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


RPRX (Royalty Pharma plc)
Benchmark (S&P 500)

RPRXWorst Drawdowns

The table below shows the maximum drawdowns of the Royalty Pharma plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Royalty Pharma plc is 32.61%, recorded on Oct 4, 2021. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-32.61%Jan 27, 2021174Oct 4, 2021
-30.41%Jun 26, 202087Oct 28, 202054Jan 15, 2021141
-3.73%Jun 19, 20201Jun 19, 20201Jun 22, 20202
-3.08%Jan 19, 20212Jan 20, 20214Jan 26, 20216
-2.03%Jun 23, 20202Jun 24, 20201Jun 25, 20203

RPRXVolatility Chart

Current Royalty Pharma plc volatility is 35.52%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


RPRX (Royalty Pharma plc)
Benchmark (S&P 500)

Portfolios with Royalty Pharma plc


Loading data...

More Tools for Royalty Pharma plc